Madduri K, Hutchinson C R
School of Pharmacy, University of Wisconsin, Madison 53706.
J Bacteriol. 1995 Mar;177(5):1208-15. doi: 10.1128/jb.177.5.1208-1215.1995.
We previously proposed that the adjacent dnrIJ genes represent a two-component regulatory system controlling daunorubicin biosynthesis in Streptomyces peucetius on the basis of the homology of the DnrI and DnrJ proteins to other response regulator proteins and the effect of a dnrI::aphII mutation. In the present paper we report the results of work with the dnrI::aphII mutant in complementation, bioconversion, and transcriptional analysis experiments to understand the function of dnrI. For five putative operons in the sequenced portion of the S. peucetius daunorubicin biosynthesis gene cluster examined, all of the potential transcripts are present in the delta dnrJ mutant and wild-type strains but absent in the dnrI::aphII strain. Since these transcripts code for both early- and late-acting enzymes in daunorubicin biosynthesis, dnrI seems to control all of the daunorubicin biosynthesis genes directly or indirectly. Transcriptional mapping of the 5' and 3' ends of the dnrIJ transcript and the termination site of the convergently transcribed dnrZUV transcript reveals, interestingly, that the two transcripts share extensive complementarity in the regions coding for daunorubicin biosynthesis enzymes. In addition, dnrI may regulate the expression of the drrAB and drrC daunorubicin resistance genes. The delta dnrJ mutant accumulates epsilon-rhodomycinone, the aglycone precursor of daunorubicin. Since this mutant contains transcripts coding for several early- and late-acting enzymes and since dnr mutants blocked in deoxysugar biosynthesis accumulate epsilon-rhodomycinone, we conclude that dnrJ is a daunosamine biosynthesis gene. Moreover, newly available gene sequence data show that the DnrJ protein resembles a group of putative aminotransferase enzymes, suggesting that the role of DnrJ is to add an amino group to an intermediate of daunosamine biosynthesis.
我们之前提出,相邻的dnrIJ基因代表一个双组分调控系统,基于DnrI和DnrJ蛋白与其他应答调节蛋白的同源性以及dnrI::aphII突变的影响,该系统控制着变铅青链霉菌中柔红霉素的生物合成。在本文中,我们报告了在互补、生物转化和转录分析实验中对dnrI::aphII突变体的研究结果,以了解dnrI的功能。对于在测序的变铅青链霉菌柔红霉素生物合成基因簇部分中的五个假定操纵子,所有潜在转录本在dnrJ缺失突变体和野生型菌株中都存在,但在dnrI::aphII菌株中不存在。由于这些转录本编码柔红霉素生物合成中早期和晚期作用的酶,dnrI似乎直接或间接控制所有柔红霉素生物合成基因。有趣的是,dnrIJ转录本5'和3'末端以及反向转录的dnrZUV转录本终止位点的转录图谱显示,这两个转录本在编码柔红霉素生物合成酶的区域具有广泛的互补性。此外,dnrI可能调节drrAB和drrC柔红霉素抗性基因的表达。dnrJ缺失突变体积聚了ε-红霉酮,即柔红霉素的糖苷配基前体。由于该突变体包含编码几种早期和晚期作用酶的转录本,并且由于在脱氧糖生物合成中受阻的dnr突变体积聚了ε-红霉酮,我们得出结论,dnrJ是一个柔红糖胺生物合成基因。此外,新获得的基因序列数据表明,DnrJ蛋白类似于一组假定的氨基转移酶,这表明DnrJ的作用是将一个氨基添加到柔红糖胺生物合成的中间体上。